Synergistic Cytotoxic Effects of Bortezomib and CK2 Inhibitor CX-4945 in Acute LymphOblastic Leukemia: Turning Off the Prosurvival ER Chaperone BIP/Grp78 and Turning on the Pro-apoptotic NF-κB
| dc.contributor.author | McCubrey, James A. | |
| dc.date.accessioned | 2022-01-31T19:21:11Z | |
| dc.date.available | 2022-01-31T19:21:11Z | |
| dc.date.issued | 2016-01-12 | |
| dc.identifier.doi | 10.18632/oncotarget.6361 | |
| dc.identifier.issn | 1949-2553 | |
| dc.identifier.uri | http://hdl.handle.net/10342/9588 | |
| dc.language.iso | en_US | en_US |
| dc.title | Synergistic Cytotoxic Effects of Bortezomib and CK2 Inhibitor CX-4945 in Acute LymphOblastic Leukemia: Turning Off the Prosurvival ER Chaperone BIP/Grp78 and Turning on the Pro-apoptotic NF-κB | en_US |
| dc.type | Article | en_US |
| ecu.journal.issue | 2 | en_US |
| ecu.journal.name | Oncotarget | en_US |
| ecu.journal.pages | 1323-1340 | en_US |
| ecu.journal.volume | 7 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- McCubreySynergisticCytotoxicEffectsofBortezomibandCK2Inhibitor.pdf
- Size:
- 4.55 MB
- Format:
- Adobe Portable Document Format
- Description:
- Article